1. A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202). Issue 12 (6th October 2021) Authors: Voorhees, Peter M.; Suman, Vera J.; Tuchman, Sascha A.; Laubach, Jacob P.; Hassoun, Hani; Efebera, Yvonne A.; Mulkey, Flora; Bova‐Solem, Misty; Santo, Katelyn; Carlisle, Destin; McCarthy, Philip L.; Richardson, Paul G. Journal: American journal of hematology Issue: Volume 96:Issue 12(2021) Page Start: 1595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022. Issue 5 (4th May 2022) Authors: Gupta, Ravi Kumar; Gupta, Ashish; Hillengass, Jens; Holstein, Sarah A.; Suman, Vera J.; Taneja, Alankrita; McCarthy, Philip L. Journal: Expert review of anticancer therapy Issue: Volume 22:Issue 5(2022) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab. Issue 4 (5th October 2020) Authors: Soh, Kah Teong; Tario, Joseph D.; Hahn, Theresa; Hillengass, Jens; McCarthy, Philip L.; Wallace, Paul K. Journal: Cytometry Issue: Volume 100:Issue 4(2021) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dextramer reagents are effective tools for quantifying CMV antigen‐specific T cells from peripheral blood samples. (23rd October 2014) Authors: Tario, Joseph D.; Chen, George L.; Hahn, Theresa E.; Pan, Dalin; Furlage, Rosemary L.; Zhang, Yali; Brix, Liselotte; Halgreen, Charlotte; Jacobsen, Kivin; McCarthy, Philip L.; Wallace, Paul K. Journal: Cytometry Issue: Volume 88:Number 1(2015) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies. (11th January 2016) Authors: Almyroudis, Nikolaos G.; Osawa, Ryosuke; Samonis, George; Wetzler, M.; Wang, Eunice S.; McCarthy, Philip L.; Segal, Brahm H. Journal: Infection control and hospital epidemiology Issue: Volume 37:Number 4(2016) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against. (12th December 2017) Authors: Richardson, Paul G.; Holstein, Sarah A.; Schlossman, Robert L.; Anderson, Kenneth C.; Attal, Michel; McCarthy, Philip L. Journal: Expert opinion on pharmacotherapy Issue: Volume 18:Number 18(2017) Page Start: 1975 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Melflufen: A Next-Generation Nitrogen Mustard. Issue 7 (1st March 2021) Authors: Holstein, Sarah A.; Hillengass, Jens; McCarthy, Philip L. Journal: Journal of clinical oncology Issue: Volume 39:Issue 7(2021) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Methodological considerations for the high sensitivity detection of multiple myeloma measurable residual disease. Issue 2 (23rd December 2019) Authors: Soh, Kah Teong; Tario, Joseph D.; Hahn, Theresa E; Hillengass, Jens; McCarthy, Philip L.; Wallace, Paul K. Journal: Cytometry Issue: Volume 98:Issue 2(2020) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation. (October 2021) Authors: Hahn, Theresa; Wang, Junke; Preus, Leah M.; Karaesmen, Ezgi; Rizvi, Abbas; Clay-Gilmour, Alyssa I.; Zhu, Qianqian; Wang, Yiwen; Yan, Li; Liu, Song; Stram, Daniel O.; Pooler, Loreall; Sheng, Xin; Haiman, Christopher A.; Berg, David Van Den; Webb, Amy; Brock, Guy; Spellman, Stephen R.; Onel, Kenan;... Journal: EClinicalMedicine Issue: Volume 40(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect. (4th March 2018) Authors: Du, Wei; Mohammadpour, Hemn; O'Neill, Rachel E.; Kumar, Sandeep; Chen, Chuan; Qiu, Michelle; Mei, Lin; Qiu, Jingxin; McCarthy, Philip L.; Lee, Kelvin P.; Cao, Xuefang Journal: Oncoimmunology Issue: Volume 7:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗